Published in Eur J Radiol on March 03, 2009
Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positive-contrast MR imaging. Radiology (2011) 1.19
Imaging of beta-cell mass and function. J Nucl Med (2010) 0.98
Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model. Mol Pharm (2011) 0.88
Non-invasive in vivo imaging of pancreatic β-cell function and survival - a perspective. Acta Physiol (Oxf) (2011) 0.85
Microcapsules with intrinsic barium radiopacity for immunoprotection and X-ray/CT imaging of pancreatic islet cells. Biomaterials (2012) 0.82
Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications. J Med Chem (2014) 0.81
Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody. Nucl Med Biol (2012) 0.81
Unique sphingomyelin patches are targets of a beta-cell-specific antibody. J Lipid Res (2011) 0.80
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. Pharmacol Rev (2016) 0.78
Targets and probes for non-invasive imaging of β-cells. Eur J Nucl Med Mol Imaging (2016) 0.75
Radiomanganese PET Detects Changes in Functional β-cell Mass in Mouse Models of Diabetes. Diabetes (2017) 0.75
In vivo imaging of islet transplantation. Nat Med (2005) 2.97
A paramagnetic CEST agent for imaging glucose by MRI. J Am Chem Soc (2003) 2.50
Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med (2008) 2.41
Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest (2006) 2.08
Sulfonylurea stimulation of insulin secretion. Diabetes (2002) 1.78
Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol (2006) 1.67
In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes (2006) 1.65
The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc Natl Acad Sci U S A (2007) 1.65
Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes (2006) 1.56
Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc Natl Acad Sci U S A (2007) 1.53
Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes (2001) 1.34
In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. J Nucl Med (2008) 1.32
Toward the Design of MR Agents for Imaging β-Cell Function. Curr Med Chem Immunol Endocr Metab Agents (2004) 1.28
Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. Biochim Biophys Acta (1999) 1.18
In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Exp Clin Endocrinol Diabetes (2005) 1.13
Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant (2006) 1.12
Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation. NMR Biomed (2007) 1.08
Identification of the potassium channel opener site on sulfonylurea receptors. J Biol Chem (1999) 1.05
Dependence of antigen expression on functional state of beta-cells. Diabetes (1990) 1.03
Advances in molecular imaging of pancreatic beta cells. Front Biosci (2008) 0.98
Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2. APMIS (1988) 0.95
Peptide-mediated targeting of the islets of Langerhans. Diabetes (2005) 0.94
Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass. Exp Clin Endocrinol Diabetes (2005) 0.91
Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent. Bioorg Med Chem Lett (2004) 0.90
Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents. Nucl Med Biol (2004) 0.89
On the track to the beta-cell. Diabetologia (2001) 0.88
Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates. Eur J Nucl Med Mol Imaging (2007) 0.87
Uptake of tritiated glibenclamide by endocrine and exocrine pancreas. Endocrine (2000) 0.87
Production and characterization of a monoclonal islet cell surface autoantibody from the BB rat. Diabetologia (1986) 0.86
Imaging of gene expression in live pancreatic islet cell lines using dual-isotope SPECT. J Nucl Med (2007) 0.84
Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats. Int J Mol Med (2000) 0.83
Immunomagnetic purification of beta cells from rat islets of Langerhans. Diabetologia (2000) 0.82
Assessment of islet beta-cell mass in isolated rat pancreases perfused with D-[(3)H]mannoheptulose. Am J Physiol Endocrinol Metab (2001) 0.81
Pancreatic fate of 6-deoxy-6-[125I]iodo-D-glucose: in vivo experiments. Endocrine (2000) 0.79
Assessment of B-cell mass in isolated islets exposed to D-[3H]mannoheptulose. Int J Mol Med (2001) 0.78
Pancreatic fate of D-[3H] mannoheptulose. Cell Biochem Funct (2001) 0.78
Pancreatic fate of 6-deoxy-6-[125I]iodo-D-glucose: in vitro experiments. Endocrine (2000) 0.77
Fate of 2-deoxy-2-[18F]fluoro-D-glucose in hyperglycemic rats. Int J Mol Med (2000) 0.77
A new approach toward a pancreas-seeking zinc radiopharmaceutical. I. Accumulation of 65Zn-amino acid and aminopolycarboxylic acid complexes in pancreatic tissue slices. Eur J Nucl Med (1986) 0.76